Skip to main content

Table 1 Numbers of study subjects in Cohorts for biomarker discovery and validation

From: Comparison of different statistical approaches for urinary peptide biomarker detection in the context of coronary artery disease

Cohort

Discovery

Validation

Validation 1 (0–5 years)

Validation 2 (5–11 years)

DICADU

39

21

  

VASCAB

93

44

  

AusDiab

144

 

74

92

CACTI

6

 

2

50

Back to article page

BMC Bioinformatics

ISSN: 1471-2105

Contact us